# A Study of Efficacy and Safety of Topiramate in the Treatment of Obese Patients With Mild to Moderate Essential Hypertension

> **NCT00236665** · PHASE3 · COMPLETED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 531 (actual)

## Conditions studied

- Obesity
- Hypertension

## Interventions

- **DRUG:** topiramate

## Key facts

- **NCT ID:** NCT00236665
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-03
- **Primary completion:** —
- **Final completion:** 2002-06
- **Target enrollment:** 531 (ACTUAL)
- **Last updated:** 2010-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00236665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00236665, "A Study of Efficacy and Safety of Topiramate in the Treatment of Obese Patients With Mild to Moderate Essential Hypertension". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00236665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*